Log In
BCIQ
Print this Print this
 

DS-1093

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionHypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN) inhibitor
Molecular Target Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia due to chronic kidney disease (CKD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today